|
United States Army Selects Med-Eng to provide its 2nd Generation Advanced Bomb Suit to Protect Explosive Ordnance Disposal Teams
Major contract award demonstrates continued confidence in Med-Eng to successfully
deliver Army programs
Supports highly-skilled manufacturing jobs in northern New York for up to four years
OGDENSBURG, New York – Med-Eng, LLC, a company of The Safariland Group, today announced it has been awarded a four-year Indefinite Delivery Indefinite Quantity (IDIQ) contract to supply the United States Army with its 2nd generation Advanced Bomb Suit (ABS II) to protect the lives of front line soldiers conducting Explosive Ordnance Disposal (EOD) operations. Program Executive Office (PEO) Soldier selected Med-Eng following a comprehensive and competitive process that evaluated protection levels, operational capabilities, human factors considerations and other requirements. Under the contract, which has a maximum value of $47 million, the Army may procure up to 1,641 Med-Eng® bomb suits during the four-year term.
“We are honored and very excited that the Army has re-affirmed its trust in Med-Eng to develop and provide proven solutions against blast threats, including Improvised Explosive Devices (IEDs),” said Rob Reynolds, vice president and general manager, Med-Eng. “Selecting Med-Eng demonstrates PEO Soldier’s continued confidence in our ability to develop an integrated suit and helmet ensemble that will provide the protection, mobility, situational awareness and technical capabilities best enabling US Army EOD operators to successfully complete their missions on the battlefield.”
Med-Eng has been providing the Army with its current fleet of ABS bomb suits since 2002. The ABS II ensemble takes advantage of new protective materials and technologies that will directly benefit EOD teams, including significant weight reduction; improved protection against blast overpressure, fragmentation, impact and heat; voice-activation of all helmet features to keep the operator’s hands free; improved ventilation to mitigate heat stress; and a user-centric design to improve ergonomics and physical flexibility.
Fulfillment of the contract will support highly skilled manufacturing operations in Ogdensburg, New York, where Med-Eng currently produces bomb suits for all four branches of the U.S. Armed Forces, as well as for state and local law enforcement bomb squads, and are used across the United States and abroad.
About Med-Eng®
The Med-Eng® brand provides integrated and battle-proven solutions for protecting frontline personnel from blast and heat threats. Its Personal Protective Equipment and specialized tools for Explosive Ordnance Disposal (EOD), bomb disposal, tactical operations and demining are trusted by military and public safety agencies in approximately 100 countries and territories worldwide. Its Crew Survivability solutions, including customized blast attenuation seats and thermal management systems, protect military vehicle crews and their mission-critical electronics. All Med-Eng equipment is engineered and rigorously tested to help save lives and enhance operational capabilities. Med-Eng is a part of The Safariland Group of brands. For more information, visit www.med-eng.com.
The Safariland Group is a leading global provider of a broad range of safety and survivability products designed for the public safety, military, professional and outdoor markets. The Safariland Group offers a number of recognized brand names in these markets including Safariland®, Bianchi®, Safariland® Armor, Mustang Survival®, Med-Eng®, Break Free®, Defense Technology®, Hatch®, Monadnock®, Identicator® and NIK®. The Safariland Group's mission, “Together, We Save Lives®”, is inherent in the lifesaving and protective products it delivers. The Safariland Group is headquartered in Jacksonville, Florida. The Safariland Group is a trade name of Safariland, LLC.
For more information about The Safariland Group and these products, please visit www.safariland.com. For media resources and information, please visit the www.safariland.com/media-center.html.
For further information, please contact:
CGPR
Meryl Rader
908.528.3826
For product information, please contact:
Med-Eng
John Carson, Marketing Director
613.851.7136